Exemple de utilizare a Enzyme inducers în Engleză și traducerile lor în Română
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Other enzyme inducers.
Thus, roflumilast treatment is not recommended in patients receiving strong cytochrome P450 enzyme inducers.
Metabolic enzyme inducers Rifabutin 300 mg QD.
Therefore, starting orending treatment with these enzyme inducers should be done with caution.
Metabolic enzyme inducers Rifabutin 300 mg 750 mg TLD QD.
Examples of contraindicated strong or moderate enzyme inducers are provided below.
Contraindicated enzyme inducers are provided in section 4.3.
The risk for liver injury after paracetamol administration is suspected to be higher in patients concomitantly treated with enzyme inducers.
Examples of contraindicated enzyme inducers are provided in section 4.3.
Strong enzyme inducers such as rifampicin or St John's wort(Hypericum perforatum) may moderately reduce the systemic exposure of lacosamide.
Major metabolic pathways of doxycycline have not been identified but enzyme inducers decrease the half-life of doxycycline.
Contraindicated enzyme inducers are provided in section 4.3 and Table 2.
Thyroid gland tumours found in a rat carcinogenicity study and hepatocellular neoplasms found in a mouse carcinogenicity study are considered to be species-specific,non-genotoxic responses associated with long-term treatment with high doses of hepatic enzyme inducers.
Coadministration with enzyme inducers may increase the risk of adverse events and ALT elevations(see Table 2).
There is a suggestion in the data that responses in combination with enzyme inducers is less than in combination with non-enzyme inducing antiepileptic agents.
Metabolic enzyme inducers: Potent inducers of CYP3A4(e.g., rifampicin, pehnobarbital and carbamazepine) may reduce nelfianvir plasma concentrations and their coadministration is contraindicated(see section 4.3).
Co-administration of dasabuvir with medicinal products that are moderate or strong enzyme inducers is expected to decrease dasabuvir plasma concentrations and reduce its therapeutic effect.
Coadministration with enzyme inducers may lead to an increased risk of adverse reactions and ALT elevations(see Table 2).
Co-administration of Exviera with medicinal products that are strong or moderate enzyme inducers is expected to decrease dasabuvir plasma concentrations and reduce its therapeutic effect see section.
Anticonvulsants that are hepatic enzyme inducers: carbamazepine, fosphenytoin, phenobarbital, phenytoin, primidone, due to the reduction of dexamethasone plasma levels and hence its efficacy.
Co-administration of Viekirax and dasabuvir with medicinal products that are moderate or strong enzyme inducers is expected to decrease ombitasvir, paritaprevir, ritonavir and dasabuvir plasma concentrations and reduce their therapeutic effect.
Some anti-epileptic drugs known as enzyme inducers(carbamazepine, phenytoin, oxcarbazepine) have been shown to increase perampanel clearance and consequently to decrease plasma concentrations of perampanel.
Therefore, the use of strong cytochrome P450 enzyme inducers(e.g. phenobarbital, carbamazepine, phenytoin) may reduce the therapeutic efficacy of roflumilast.
Therefore, the use of strong CYP3A4 enzyme inducers(e.g. rifampicin, phenobarbital, carbamazepine, phenytoin and St. John's Wort) with apremilast is not recommended.
Therefore, co-administration of Senshio with strong enzyme inducers like carbamazepine, phenytoin, St John's wort and rifabutin would be expected to decrease the exposure of ospemifene, which may decrease the clinical effect.
Co-administration of Viekirax with or without dasabuvir with medicinal products that are strong or moderate enzyme inducers is expected to decrease ombitasvir, paritaprevir, and ritonavir plasma concentrations and reduce their therapeutic effect and must not be co-administered(see section 4.5).
Lenalidomide is not an enzyme inducer.
Dexamethasone is a weak to moderate enzyme inducer and its effect on warfarin is unknown.
Rifampicin, a strong CYP3A/ CYP2C9 enzyme inducer, decreased the AUC of ospemifene by 58%.
Carbamazepine, a known potent enzyme inducer, reduced perampanel levels by two-thirds in a study performed on healthy subjects.